SubHero Banner
Text

Ruzurgi (amifampridine)  – New orphan drug approval

May 6, 2019 - The FDA announced the approval of Jacobus’ Ruzurgi (amifampridine), for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age.

Download PDF